Current status: 1135 hESC lines, 8173 hiPSC lines, and 205 clinical studies, and 2407 certificates
Monthly statistic from Sep 1, 2026
Posted on September 1, 2026
| total lines | 9308 |
| hESC lines | 1135 |
| hiPSC lines | 8173 |
| derivation countries | 52 |
| projects | 347 |
| providers | 1071 |
| clinical studies | 205 |
| subclones | 4245 |
| certificates | 2407 |
| cell line certificates | 2246 |
| project certificates | 161 |